China Court Official Says Number Of Fake-Drug Cases Increased By 70%
This article was originally published in PharmAsia News
China's legal authorities say the courts have seen a large increase in the number of cases involving drug and food safety, but attributed the surge to the system's own oversight.
You may also be interested in...
Novartis has been tipped to regain dominance in AMD, but Bayer/Regeneron have also gained 12-week dosing approval.
Xellia has added a 500mg/100ml variant to its range of vancomycin ready-to-use bags in the US, while Kabi has introduced ertapenem 1g vials and struck a critical-care supply deal with Vizient.